ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 179 filers reported holding ALLOGENE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.67 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $236,204 | -47.9% | 101,375 | 0.0% | 0.01% | -40.0% |
| Q1 2024 | $453,146 | +91.2% | 101,375 | +37.3% | 0.01% | +42.9% |
| Q4 2023 | $236,946 | +1.3% | 73,815 | 0.0% | 0.01% | -12.5% |
| Q3 2023 | $233,994 | +21.2% | 73,815 | +90.1% | 0.01% | +33.3% |
| Q2 2023 | $193,010 | +0.6% | 38,835 | 0.0% | 0.01% | -14.3% |
| Q1 2023 | $191,845 | +5.2% | 38,835 | +34.0% | 0.01% | +16.7% |
| Q4 2022 | $182,278 | -7.5% | 28,979 | +59.0% | 0.01% | -14.3% |
| Q3 2022 | $197,000 | -52.6% | 18,229 | -50.0% | 0.01% | 0.0% |
| Q2 2022 | $416,000 | +150.6% | 36,458 | +100.0% | 0.01% | +40.0% |
| Q1 2022 | $166,000 | -39.0% | 18,229 | 0.0% | 0.01% | -37.5% |
| Q4 2021 | $272,000 | -41.9% | 18,229 | 0.0% | 0.01% | -46.7% |
| Q3 2021 | $468,000 | -1.5% | 18,229 | 0.0% | 0.02% | -6.2% |
| Q2 2021 | $475,000 | -26.1% | 18,229 | 0.0% | 0.02% | -33.3% |
| Q1 2021 | $643,000 | +39.8% | 18,229 | 0.0% | 0.02% | +41.2% |
| Q4 2020 | $460,000 | -33.0% | 18,229 | 0.0% | 0.02% | -43.3% |
| Q3 2020 | $687,000 | -23.2% | 18,229 | -12.7% | 0.03% | -23.1% |
| Q2 2020 | $894,000 | +103.6% | 20,886 | -7.6% | 0.04% | +85.7% |
| Q1 2020 | $439,000 | -24.8% | 22,606 | +0.6% | 0.02% | +31.2% |
| Q4 2019 | $584,000 | -4.6% | 22,465 | 0.0% | 0.02% | 0.0% |
| Q3 2019 | $612,000 | +1.5% | 22,465 | 0.0% | 0.02% | +6.7% |
| Q2 2019 | $603,000 | – | 22,465 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 1,798,163 | $4,189,720 | 4.58% |
| SUPERSTRING CAPITAL MANAGEMENT LP | 689,912 | $1,607,495 | 2.03% |
| Lynx1 Capital Management LP | 2,228,295 | $5,191,927 | 1.87% |
| Wildcat Capital Management, LLC | 2,920,787 | $6,805,434 | 1.66% |
| TPG GP A, LLC | 18,716,306 | $43,608,993 | 1.00% |
| Boxer Capital, LLC | 3,850,000 | $8,970,500 | 0.47% |
| Vestal Point Capital, LP | 2,200,000 | $5,126,000 | 0.38% |
| DAFNA Capital Management LLC | 605,100 | $1,409,883 | 0.34% |
| Frazier Life Sciences Management, L.P. | 2,867,750 | $6,681,858 | 0.31% |
| Coastal Bridge Advisors, LLC | 406,847 | $947,954 | 0.24% |